Annotation Detail for GIT1

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa04144 | Endocytosis |
hsa05120 | Epithelial cell signaling in Helicobacter pylori infection |
hsa04810 | Regulation of actin cytoskeleton |
Pathway ID | Pathway Name |
---|
200178 | Paxillin-independent events mediated by a4b1 and a4b7 |
200155 | Stabilization and expansion of the E-cadherin adherens junction |
200060 | Arf6 signaling events |
200166 | Aurora A signaling |
200117 | Paxillin-dependent events mediated by a4b1 |
200059 | Regulation of CDC42 activity |
Desease ID | Desease Name |
---|
1745 | Huntington disease |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GIT1 mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of GIT1 mRNA | affects expression | 16483693
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in increased expression of GIT1 mRNA | increases expression | 20360939
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.30 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
3.08 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.64 | 17162532 19052882 16434500 17620307 18056438 19061943 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.19 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.15 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.15 | 20512989 18788625 19394651 18210153 20432363 20727157 19107877 19701751 18056438 16878318 19822196 18506893 18665156 17138121 11831363 19171122 3581430 3084413 17428255 17978847 16779866 16502159 16698587 19539802 18691550 20514400 10737359 19052882 18494052 16328049 20084675 18393292 18978308 17173139 18971187 16288022 19383236 19919837 19418558 10672840 20935162 16569478 16807293 16540662 19335982 17055752 20101231 16935385 20524982 19208518 16681979 16830150 17761372 20214788 17162532 20007298 18785209 21159647 19519916 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
3.15 | 7505956 17174075 2727394 21159647 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
4.10 | 19052882 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.67 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.27 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
4.22 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
4.22 | 19107877 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.98 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.67 | 21071580 20387270 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.57 | 18785209 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.36 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
3.03 | 18407596 19638242 20032147 18665156 18522880 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.18 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
2.36 | 19499222 9163691 19638242 20492335 19294768 2422723 20452335 19256749 19426721 20501860 18644402 20583210 21278145 18978307 18754104 10737359 19690152 19090486 12112319 21047994 12771043 19551842 20137499 19833225 19255062 2862719 18977376 19812893 20101389 20405173 19254457 19073162 18648771 21071580 19996281 21167192 15175105 19850985 20434301 16942905 19642983 19427195 20118626 15885732 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
2.88 | 19519916 9362446 16267830 18544905 19539802 18308698 18775883 19126423 18079962 17174075 19009564 21159647 17942915 2563599 18253720 17854601 16842330 19004024 3124819 18282651 18164116 18093689 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
1.77 | 6695378 20970405 20512841 21163286 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.60 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.70 | 9029167 3581430 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.73 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.98 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.88 | 16049721 12819281 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.54 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.97 | 2563599 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.81 | 18551238 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.32 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.42 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
5.06 | 10091137 |
Pathway ID |
Pathway Name |
---|
KEGG:04144 |
Endocytosis |
KEGG:05120 |
Epithelial cell signaling in Helicobacter pylori infection |
KEGG:04810 |
Regulation of actin cytoskeleton |
PharmGKB Accession:PA28683
Releated drug ID |
Related drug Name |
PA449177 | cytarabine |